The effectiveness of psychoanalytic/psychodynamic psychotherapy for reducing suicide attempts and self-harm: Systematic review and meta-analysis
Briggs, S., Netuveli, G., Gould, N., Gkaravella, A., Gluckman, N., Kangogyere, P., Farr, R., Goldblatt, M. and Lindner, R. 2019. The effectiveness of psychoanalytic/psychodynamic psychotherapy for reducing suicide attempts and self-harm: Systematic review and meta-analysis. British Journal of Psychiatry. 214 (6), pp. 320-328.
|Authors||Briggs, S., Netuveli, G., Gould, N., Gkaravella, A., Gluckman, N., Kangogyere, P., Farr, R., Goldblatt, M. and Lindner, R.|
Preventing suicide and self-harm is a global health priority. Although there is a growing evidence-base for the effectiveness of psychoanalytic and psychodynamic psychotherapies for a range of disorders, to date there has been no systematic review of its effectiveness in reducing suicidal and self-harming behaviours.
To systematically review randomised controlled trials (RCTs) of psychoanalytic and psychodynamic psychotherapies for suicidal attempts and self-harm.
We searched PubMed, PsycINFO, Psycharticles, CINAHL, EMBASE, and the Cochrane Central Register of Controlled Trials for RCTs of psychoanalytic and psychodynamic psychotherapies for reducing suicide attempts and self-harm.
Twelve trials (17 articles) were included in the meta-analyses. Psychoanalytic and psychodynamic therapies were effective in reducing the number of patients attempting suicide (pooled odds ratio = 0.469, 95% CI 0.274 to 0.804). We found some evidence for significantly reduced repetition of self-harm at 6-month follow-up, though not at 12 months.
Significant treatment effects were also found for improvements in psychosocial functioning and reduction in number of hospital admissions.
Psychoanalytic and psychodynamic psychotherapies are indicated to be effective in reducing suicidal behaviour and to have short-term effectiveness in reducing self-harm. They can also be beneficial in improving psychosocial well-being. However, the small number of trials and moderate quality of the evidence means further high quality trials are needed to confirm our findings and to identity which specific components of the psychotherapies are effective.
|Journal||British Journal of Psychiatry|
|Journal citation||214 (6), pp. 320-328|
|Publisher||Cambridge University Press|
|Accepted author manuscript|
|Digital Object Identifier (DOI)||doi:10.1192/bjp.2019.33|
|Web address (URL)||https://doi.org/10.1192/bjp.2019.33|
|Online||28 Feb 2019|
|Publication process dates|
|Deposited||11 Feb 2019|
|Accepted||13 Jan 2019|
|Accepted||13 Jan 2019|
|Copyright information||This article has been published in a revised form in British Journal of Psychiatry: http://doi.org/10.1192/bjp.2019.33. This version is published under a Creative Commons CC-BY-NC-ND. No commercial re-distribution or re-use allowed. Derivative works cannot be distributed. © 2019 The Royal College of Psychiatrists.|
20views this month
15downloads this month